Astrana Health Analyst Price Targets - Benzinga

Astrana Health Inc

ASTHNASDAQ

Trade with Public

Trade with Public

$37.96

-0.45-1.17%

In chiusura: Aug 28, 5:00 PM EST

$37.96

N/A

Post-mercato: Aug 28, 4:00 PM EST

Panoramica Notizie Previsioni utili EventiObiettivi di prezzoDati finanziari Sentiment Azionariato Confronta Opzioni Rapporto azionario

Astrana Health Analyst Price Targets

Wall Street analyst price targets and consensus rating for Astrana Health (ASTH).

Price Target Range — 10 Quarters

Analyst Consensus — 9 Analysts

9Buy

Consensus RatingBuy# Analysts9Avg. Consensus PT$50Upside to Avg. PT+30.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 11, 2026	Truist Securities	Jailendra Singh	PT Raise	Buy	$47→$55
Aug 7, 2026	Barclays	Andrew Mok	PT Raise	Overweight	$50→$53
Jul 14, 2026	TD Cowen	Ryan Langston	PT Raise	Buy	$45→$50
Jul 14, 2026	BTIG	David Joyce	PT Raise	Buy	$50→$65
Jun 2, 2026	BTIG	David Larsen	Maintained	Buy	$50
May 26, 2026	Barclays	Andrew Mok	Upgrade	Equal-Weight→Overweight	$37→$50
May 14, 2026	Truist Securities	Jailendra Singh	PT Raise	Buy	$38→$47
May 12, 2026	TD Cowen	Ryan Langston	PT Raise	Buy	$35→$45
May 11, 2026	Barclays	Andrew Mok	PT Raise	Equal-Weight	$26→$37
May 8, 2026	BTIG	David Larsen	PT Raise	Buy	$40→$50
May 8, 2026	Needham	Matthew Shea	PT Raise	Buy	$30→$41
Apr 15, 2026	Baird	Michael Ha	PT Raise	Outperform	$37→$40
Mar 13, 2026	Truist Securities	Jailendra Singh	PT Raise	Buy	$37→$38
Feb 2, 2026	BTIG	David Larsen	PT Cut	Buy	$45→$40
Dec 12, 2025	Needham	Matthew Shea	Initiate	Buy	$28
Nov 25, 2025	Jefferies	Jack Slevin	PT Cut	Buy	$44→$37
Nov 24, 2025	Barclays	Andrew Mok	PT Cut	Equal-Weight	$36→$26
Nov 10, 2025	TD Cowen	Ryan Langston	PT Cut	Buy	$40→$35
Nov 7, 2025	BTIG	David Larsen	PT Cut	Buy	$50→$45
Apr 1, 2025	Barclays	Andrew Mok	Initiate	Equal-Weight	$36

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Truist Securities Maintains Buy on Astrana Health, Raises Price Target to $55

Truist Securities analyst Jailendra Singh maintains Astrana Health (NASDAQ:ASTH) with a Buy and raises the price target from $47 to $55.

Benzinga Newsdesk

PRO
Barclays Maintains Overweight on Astrana Health, Raises Price Target to $53

Barclays analyst Andrew Mok maintains Astrana Health (NASDAQ:ASTH) with a Overweight and raises the price target from $50 to $53.

Benzinga Newsdesk

PRO
TD Cowen Maintains Buy on Astrana Health, Raises Price Target to $50

TD Cowen analyst Ryan Langston maintains Astrana Health (NASDAQ:ASTH) with a Buy and raises the price target from $45 to $50.

Benzinga Newsdesk

PRO
BTIG Maintains Buy on Astrana Health, Raises Price Target to $65

BTIG analyst David Joyce maintains Astrana Health (NASDAQ:ASTH) with a Buy and raises the price target from $50 to $65.

Benzinga Newsdesk

PRO
BTIG Reiterates Buy on Astrana Health, Maintains $50 Price Target

BTIG analyst David Larsen reiterates Astrana Health (NASDAQ:ASTH) with a Buy and maintains $50 price target.

Benzinga Newsdesk

PRO
Barclays Upgrades Astrana Health to Overweight, Raises Price Target to $50

Barclays analyst Andrew Mok upgrades Astrana Health (NASDAQ:ASTH) from Equal-Weight to Overweight and raises the price target from $37 to $50.

Benzinga Newsdesk